ATLANT 3D Nanosystems Developing a Space-certified Nanofabricator 0G
31.3.2022 10:59:00 EEST | Business Wire | Press release
ATLANT 3D Nanosystems announces today the collaboration with ESA BIC to further advance the development of ATLANT 3D Nanofabricator™ 0G systems, the first-ever zero gravity R&D system that allows selective area direct write atomic layer precision.
ATLANT 3D™ will develop a space-certified Nanofabricator 0G with the goal of going to the International Space Station (ISS) in future missions. The machine will have the full capabilities of the Nanofabricator Lite system, allowing further testing and development of on-demand electronic materials and micro and nanodevice prototyping. This will further enable researchers and innovators with rapid materials and device development in Space.
This unique technology will be it first of its kind in Space and it all started with NASA purchasing ATLANT 3D’s first 0G system, allowing ATLANT 3D to develop unique new technologies for bringing Microreactor Selective Area Direct Atomic Processing (μSADALP™) technology into Space.
About ATLANT 3D Nanosystems
https://atlant3d.com
ATLANT 3D is a Danish startup company that is developing a fundamentally different and innovative micro and nanofabrication platform technology. ATLANT 3D is a developer of high-performance technology enables atomical precise advanced manufacturing of the next generation of advanced materials and electronics. ATLANT 3D team is highly dynamic, international, and multidisciplinary, consisting of 15 experienced entrepreneurs, engineers and scientists. ATLANT 3D collaborates with leading European universities, such as SAS, DTU, FAU, TNO, SUPSI and industrial partners such as Merck, ST Microelectronics, Prima Industrie and SEMPA.
About ESA BIC
https://www.esabic.dk
ESA BIC Denmark is the 21st member of ESA’s pan-European network of Business Incubation Centres. The incubator is led by The Technical University of Denmark (DTU) in collaboration with the Danish Ministry for Higher Education and Science, University of Aalborg, University of Aarhus, The Danish Industry Foundation and other partners from academia, science parks, industry and Danish government agencies. The main objective of the Danish ESA BIC is to create and strengthen communities of successful space related start-ups in Denmark The activities will contribute significantly to growing clusters of space-based companies in Denmark.
Social media links:
LinkedIn: https://www.linkedin.com/company/atlant3dnano
Twitter: https://twitter.com/Atlant3d
Youtube: https://www.youtube.com/channel/UC6ffxaIzDjy_jr4jILQQaqw
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005773/en/
Contact information
Albina Nazari
Marketing & Communication Manager
ATLANT 3D Nanosystems
Email: an@atlant3d.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Bolivarian Republic of Venezuela Announces the Initiation of a Comprehensive Public Debt Restructuring Process13.5.2026 23:08:00 EEST | Press release
The Bolivarian Republic of Venezuela announces today its decision to initiate a comprehensive restructuring of its external public debt obligations. CONTEXT & RATIONALE Over the past decade, Venezuela's economy has been severely impacted by external shocks – from the end of the commodity super-cycle to foreign sanctions and COVID-19 – resulting in a sharp economic contraction, a protracted default since 2017, and a ballooning of public sector liabilities. The country nonetheless possesses a strong economic potential, including unique hydrocarbon and mineral endowments. A recovery is underway, and Venezuela is committed to accelerating it through a comprehensive reform agenda in support of growth, fiscal sustainability, monetary stabilization, and enhanced governance. Restoring public debt sustainability is central to this agenda: the current debt overhang constrains external financing, limits public investment capacity, and prevents full re-engagement with the international financial s
Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise13.5.2026 22:00:00 EEST | Press release
Boomi, the data activation company for AI, today announced it has signed a letter of intent to acquire Lunar.dev, an innovator in AI and MCP gateway. The proposed acquisition is expected to enrich the Boomi Enterprise Platform and Boomi Connect with advanced capabilities to govern and scale AI usage across enterprise systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513850557/en/ Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise As organizations move from AI experimentation to production, controlling how agents and AI applications interact with LLMs at scale has become critical. Lunar.dev addresses this need with an AI gateway that delivers granular, policy-driven control over AI interactions, with the visibility, security, and performance required for enterprise environments. These capabilities enable organizations to move from pilot to production with confiden
BeOne Medicines’ BEQALZI ™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma13.5.2026 20:27:00 EEST | Press release
BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BEQALZI™(bee-KAHL-zee; sonrotoclax), a foundational, next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase (BTK) inhibitor. BEQALZI was designed to enhance BCL2 inhibition—with greater potency, selectivity, and a pharmacologic profile with potential to improve efficacy, tolerability, and convenience over others in the class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513542161/en/ BeOne Medicines' flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J. Michael Wang, M.D., Global Principal Investigator
Boomi Unveils Innovations That Power the Agentic Enterprise13.5.2026 17:30:00 EEST | Press release
Boomi, the data activation company for AI, today announced a major expansion of the Boomi Enterprise Platform at Boomi World 2026, introducing new capabilities across orchestrated agentic workflows, agentic engineering, governed agent connectivity, grounded agent context, and localized agent infrastructure. Together, these innovations are designed to power the agentic enterprise — where agents and humans work together to drive action and operationalize AI at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513996223/en/ Boomi Unveils Innovations That Power the Agentic Enterprise The enterprise has reached a defining moment as AI becomes the primary interface for work and MCP emerges as the new standard. While the shift toward a headless, agentic enterprise is inevitable, this vision is colliding with skyrocketing cloud costs and trapped data. For many, layering agents onto a fragmented landscape only magnifies govern
Boomi and Couchbase Partner to Power Enterprise AI Agents with Trusted Recollection, Connectivity, and Governance13.5.2026 17:30:00 EEST | Press release
Boomi, the data activation company for AI, and Couchbase, Inc., the operational data platform for AI, today announced a partnership through which the two companies are collaborating closely to accelerate AI pilots to production. The companies will co-engineer solutions that give customers a production-ready foundation for agentic AI, combining Boomi's connectivity, runtime, and governance for AI agents with Couchbase's scalable recollection and vector capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513350337/en/ Enterprises deploying AI agents today face a common challenge: while agents perform well in pilots, they struggle to scale due to inconsistent access to trusted context, recollection, and real-time business data. Lack of governance, auditability, and operational control drives up compute costs while diminishing productivity and revenue. “2026 is the year organizations move from AI experimentation to a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom